TrialCancer discovery2018

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer.

David T Miyamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.